A meta-analysis of 27 studies of 698 controls and 1545 patients with NAFLD found that serum adiponectin levels are low in NAFLD and much lower in NASH [36]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.